Keng-Chang Tsai

8PUBLICATIONS
21CO-AUTHORS
Medical molecular engineering of nucleic acids and proteinsCancer therapy (excl. chemotherapy and radiation therapy)Innate immunityMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Feb 27, 2026
NRICM102, a TCM Formula, Attenuates COPD-Relevant Inflammatory Lung Injury in Mice by Improving Pulmonary Function and Reversing Immune Dysregulation.

Yuh-Chiang Shen, Kuo-Tong Liou, Yea-Hwey Wang

|Jan 31, 2025
Synergistic effect of inhibiting CHK2 and DNA replication on cancer cell growth.

Flavie Coquel, Sing-Zong Ho, Keng-Chang Tsai

|Feb 15, 2024
Structure-Guided Discovery of PD-1/PD-L1 Interaction Inhibitors: Peptide Design, Screening, and Optimization via Computation-Aided Phage Display Engineering.

Tien-Sheng Tseng, Chao-Chang Lee, Po-Juei Chen

|Apr 27, 2023
The Blockade of Mitogen-Activated Protein Kinase 14 Activation by Marine Natural Product Crassolide Triggers ICD in Tumor Cells and Stimulates Anti-Tumor Immunity.

Keng-Chang Tsai, Chia-Sheng Chen, Jui-Hsin Su

|Sep 20, 2021
Pdia4 regulates β-cell pathogenesis in diabetes: molecular mechanism and targeted therapy.

Tien-Fen Kuo, Shuo-Wen Hsu, Shou-Hsien Huang

|Mar 20, 2020
Astragalus membranaceus-Derived Anti-Programmed Death-1 Monoclonal Antibodies with Immunomodulatory Therapeutic Effects against Tumors.

Fu-Ling Chang, Keng-Chang Tsai, Tsai-Yu Lin

Pageof 2

Frequent Collaborators

2 joint publications

Wen-Chin Yang

1 joint publications

Chen-Yu Chen

1 joint publications

Yun Yen

1 joint publications

Shiow-Lin Pan